BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 15040942)

  • 1. Clearance of Helicobacter pylori infection through immunization: the site of T cell activation contributes to vaccine efficacy.
    Blanchard TG; Eisenberg JC; Matsumoto Y
    Vaccine; 2004 Feb; 22(7):888-97. PubMed ID: 15040942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eradication of Helicobacter pylori and resolution of gastritis in the gastric mucosa of IL-10-deficient mice.
    Matsumoto Y; Blanchard TG; Drakes ML; Basu M; Redline RW; Levine AD; Czinn SJ
    Helicobacter; 2005 Oct; 10(5):407-15. PubMed ID: 16181351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
    Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
    Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD25+/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo.
    Rad R; Brenner L; Bauer S; Schwendy S; Layland L; da Costa CP; Reindl W; Dossumbekova A; Friedrich M; Saur D; Wagner H; Schmid RM; Prinz C
    Gastroenterology; 2006 Aug; 131(2):525-37. PubMed ID: 16890606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-specific in vitro suppression of murine Helicobacter pylori-reactive immunopathological T cells by CD4CD25 regulatory T cells.
    Raghavan S; Suri-Payer E; Holmgren J
    Scand J Immunol; 2004; 60(1-2):82-8. PubMed ID: 15238076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation, immunity and vaccines for Helicobacter pylori.
    Del Giudice G; Michetti P
    Helicobacter; 2004; 9 Suppl 1():23-8. PubMed ID: 15347302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective anti-Helicobacter immunity is induced with aluminum hydroxide or complete Freund's adjuvant by systemic immunization.
    Gottwein JM; Blanchard TG; Targoni OS; Eisenberg JC; Zagorski BM; Redline RW; Nedrud JG; Tary-Lehmann M; Lehmann PV; Czinn SJ
    J Infect Dis; 2001 Aug; 184(3):308-14. PubMed ID: 11443556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The current status of Helicobacter pylori vaccines: a review.
    Kabir S
    Helicobacter; 2007 Apr; 12(2):89-102. PubMed ID: 17309745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori immunology and vaccines.
    Vorobjova T; Watanabe T; Chiba T
    Helicobacter; 2008 Oct; 13 Suppl 1():18-22. PubMed ID: 18783517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nontoxic CTA1-DD adjuvant enhances protective immunity against Helicobacter pylori infection following mucosal immunization.
    Akhiani AA; Stensson A; Schön K; Lycke N
    Scand J Immunol; 2006 Feb; 63(2):97-105. PubMed ID: 16476008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAR2 promotes vaccine-induced protection against Helicobacter infection in mice.
    Velin D; Narayan S; Bernasconi E; Busso N; Ramelli G; Maillard MH; Bachmann D; Pythoud C; Bouzourene H; Michetti P; So A
    Gastroenterology; 2011 Oct; 141(4):1273-82, 1282.e1. PubMed ID: 21703999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of Helicobacter pylori infection.
    Lee A
    Scand J Gastroenterol Suppl; 1996; 215():11-5. PubMed ID: 8722377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in vaccination against Helicobacter pylori.
    Velin D; Michetti P
    Expert Rev Gastroenterol Hepatol; 2010 Apr; 4(2):157-66. PubMed ID: 20350263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a new tumor necrosis factor-alpha-inducing membrane protein of Helicobacter pylori as a prophylactic vaccine antigen.
    Inoue K; Shiota S; Yamada K; Gotoh K; Suganuma M; Fujioka T; Ahmed K; Iha H; Nishizono A
    Helicobacter; 2009 Oct; 14(5):135-43. PubMed ID: 19751439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies.
    Wilson KT; Crabtree JE
    Gastroenterology; 2007 Jul; 133(1):288-308. PubMed ID: 17631150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses.
    Nyström J; Svennerholm AM
    Vaccine; 2007 Mar; 25(14):2591-8. PubMed ID: 17239498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori vaccine development: optimisation of strategies and importance of challenging strain and animal model.
    Hoffelner H; Rieder G; Haas R
    Int J Med Microbiol; 2008 Jan; 298(1-2):151-9. PubMed ID: 17714988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation, immunity, vaccines for Helicobacter infection.
    Chmiela M; Michetti P
    Helicobacter; 2006 Oct; 11 Suppl 1():21-6. PubMed ID: 16925607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A truncated form of HpaA is a promising antigen for use in a vaccine against Helicobacter pylori.
    Flach CF; Svensson N; Blomquist M; Ekman A; Raghavan S; Holmgren J
    Vaccine; 2011 Feb; 29(6):1235-41. PubMed ID: 21147129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against Helicobacter pylori infection in mongolian gerbil by intragastric or intramuscular administration of H. pylori multicomponent vaccine.
    Wu C; Shi Y; Guo H; Zou WY; Guo G; Xie QH; Mao XH; Tong WD; Zou QM
    Helicobacter; 2008 Jun; 13(3):191-9. PubMed ID: 18466394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.